Front Row Advisors’s Allergan plc AGN.PRA Stock Holding History

Front Row Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2	Closed	-$1K	–	990
2017 Q4	$1K	Buy	+2	New	+$1.29K	﹤0.01%	827

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Front Row Advisors's AGN.PRA Position: Q1 2018 in Review

Front Row Advisors sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 2 shares — an estimated $1K sold.

Front Row Advisors first reported a position in AGN.PRA in Q4 2017 and held it in 1 quarter. The position peaked at $1K in Q4 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Front Row Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Front Row Advisors sold 2 Allergan plc shares in Q1 2018, an estimated $1K.
Front Row Advisors first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Front Row Advisors's Allergan plc position peaked at $1K in Q4 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Front Row Advisors's 13F filing for Q1 2018, filed 21 May 2018.